Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 16/20 | 0.82 |
| ▸ | HTR1A | P08908 | 14/20 | 0.82 |
| ▸ | SLC6A3 | Q01959 | 7/20 | 0.67 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.60 |
| ▸ | HTR2C | P28335 | 3/20 | 0.50 |
| ▸ | HTR2B | P41595 | 3/20 | 0.50 |
| ▸ | HRH1 | P35367 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23830677 | 1.00 | SLC6A2 (0.82) | SLC6A2HTR1ASLC6A3SLC6A4HTR2C | |
| SCHEMBL23830680 | 1.00 | SLC6A2 (0.82) | SLC6A2HTR1ASLC6A3SLC6A4HTR2C | |
| SCHEMBL234075 | 0.90 | SLC6A2 (0.72) | SLC6A2HTR1ASLC6A3SLC6A4 | |
| SCHEMBL234010 | 0.89 | SLC6A2 (0.81) | SLC6A2HTR1ASLC6A3SLC6A4HTR2C | |
| Hydrochloric Acid SCHEMBL3466964 | 0.88 | SLC6A2 (0.79) | SLC6A2HTR1ASLC6A3SLC6A4HTR2C | |
| SCHEMBL3832571 | 0.85 | SLC6A2 (0.80) | SLC6A2HTR1ASLC6A3SLC6A4 | |
| Hydrochloric Acid SCHEMBL14862180 | 0.84 | SLC6A2 (0.77) | SLC6A2HTR1ASLC6A3SLC6A4 | |
| SCHEMBL30791459 | 0.84 | SLC6A2 (0.64) | SLC6A2HTR1ASLC6A3SLC6A4HRH1 | |
| SCHEMBL23161332 | 0.83 | SLC6A2 (0.64) | SLC6A2HTR1ASLC6A3SLC6A4HTR2C | |
| Hydrochloric Acid SCHEMBL23146510 | 0.82 | SLC6A2 (0.62) | SLC6A2HTR1ASLC6A3SLC6A4HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101583600-A | Acetylene derivatives as stearoyl-CoA desaturase inhibitors | GLENMARK PHARMACEUTICALS SA (CH) | 2009-11-18 | — | — | CN | disclosed |
| US-20080182851-A1 | ACETYLENE DERIVATIVES AS STEAROYL COA DESATURASE INHIBITORS | GLENMARK PHARMACEUTICALS S.A. (CH) | 2008-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080182851-A1 | ACETYLENE DERIVATIVES AS STEAROYL COA DESATURASE INHIBITORS | SCD, SCD5, ACACA | SLC6A2 4488/4885HTR1A 3789/4885SLC6A3 4681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.